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Abstract
Background: Reproductive failure in sow herds due to infection with influenza A viruses has been described in the
literature, but only a few studies have focused on the pathogenesis and the clinical signs of the infection. Case
reports indicate an association between infections with influenza A viruses and reduced reproductive performance,
although it has been difficult to experimentally reproduce the clinical outcome of poor reproductive performance.
The aim of the present longitudinal field study was to compare the reproductive performance parameters before
and after the implementation of vaccination against the influenza A (H1N1)pdm09 virus in sow herds infected with
pandemic influenza A virus. Therefore, farm-specific data of 137 sow herds in Germany, including 60,153 sows, as
well as the clinical presentation of the infection were surveyed via questionnaire. Furthermore, average performance
parameters (return to oestrus rate, abortion rate, stillbirth rate, number of piglets born alive per litter, preweaning
mortality rate and number of piglets weaned per sow per year) were recorded for 6months before vaccination and 6
months after completion of primary vaccination.
Results: In 79.8% of the farms, the clinical presentation of the infection was characterised by a reduced reproductive
performance. These findings were confirmed by analysis of the performance parameters, which revealed a significant
decline in the return to oestrus rate (p < 0.001), abortion rate (p < 0.001) and preweaning mortality rate (p = 0.023) and
a significant increase of the number in piglets born alive (p = 0.001) and piglets weaned per sow per year (p < 0.001)
after immunisation. The stillbirth rate did not change significantly.
Conclusion: The present study represents the first attempt to demonstrate the association of influenza A virus
infection, vaccination and the alteration in reproductive performance parameters, investigating a large number of
cases. The results show that by vaccinating against the influenza A (H1N1)pdm09 virus, an improvement in
reproductive performance can be achieved in sow herds infected with pandemic influenza A virus. Additionally,
the large number of herds that were affected by poor reproductive performance after infection with the aforementioned
virus confirms the assumption of an association between pandemic influenza A virus and reproductive losses.
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Background
In April 2009, the influenza A (H1N1)pdm09 virus was
detected in humans and, shortly after, provoked the first
pandemic of the twenty-first century [1, 2]. Simultan-
eous to the global spread in humans, the virus emerged
in pig farms across the world [3–6]. The porcine origin
of the virus is uncontroversial and underlines the im-
portance of the pig as a host for the virus [7].
Influenza A virus (IAV) is a potential pathogen of
zoonotic disease and causes worldwide important eco-
nomic losses [8, 9]. Pathogenesis studies have shown
that in pigs as well as in all other mammals viral in-
fection and replication is limited to the respiratory
tract [10]. Independent of the subtype, the disease
can emerge both in a subclinical and in an acute way,
with varying severity, showing febrile illness together
with respiratory disease [4, 8, 11]. An involvement in
reproductive disorders, such as return to oestrus,
abortion or small litters, is assumed, although a
causal link could not be shown in all studies [12, 13].
Numerous case reports as well as a case-control study
on a naive Norwegian pig subpopulation describe the
emergence of reproductive disorders in context with
the infection with influenza A virus [14–17]. In con-
trast, there are few experimental studies investigating
the pathogenesis and the clinical presentation of the
reproductive losses [18–20]. The clinical presentation
was not reproducible in these studies. Thus, a valid-
ation of a causal link between the virus infection and
inadequate reproductive performance is still lacking.
Subsequent to the emergence of the pandemic influ-
enza A virus, a new vaccine against this subtype was
developed. The results of the clinical studies for
efficacy and safety were verified under field conditions
in 315 farms infected with pandemic influenza A
virus. A majority of the sows in the affected farms
where IAV was circulating showed remarkably re-
duced reproductive performance. The present longitu-
dinal field study was conducted to evaluate the effect
of pandemic IAV on the reproductive parameters and
vaccination of animals in conventional sow herds.
Results
Clinical signs
Clinical signs prior to vaccination were recorded in 129
farms (Additional file 1, Table S1). Due to information
bias, the clinical signs could not be evaluated in eight
farms. Reduced reproductive performance was observed
in 79.8% (n = 103/129) of the farms. The clinical presen-
tation was characterised by fever and respiratory disease
(cough) in 62.8% (n = 81/129) and 61.2% (n = 79/129) of
the farms, respectively. Dyspnoea was apparent in 17.1%
(n = 22/129), reduced feed intake in 39.5% (n = 51/129)
and apathy in 14.7% (n = 19/129) of the farms.
Reproductive performance
Analysis of the return to oestrus rate revealed, on aver-
age, a significant (p < 0.001) decline of 3.34% after im-
munisation (Table 1).
In 74.8% of the farms (n = 98/131) a significant reduc-
tion (p < 0.001) in the return to oestrus rate was observed
after implementation of vaccination (Table 1). In those
farms, the mean return to oestrus rate was significantly
(p < 0.001) reduced by 5.1% (± 4.66). Overall, in 3 farms
(2.2%) none of the assessed reproductive parameters im-
proved. The number of farms varies for each parameter
Table 1 Reproductive performance data prior to and after implementation of vaccination
before vaccination after vaccination alteration in the farms
parameter mean median mean median p-valuea decrease (%) stagnation (%) increase (%)
(n = number of farms) (SD) (Q25; Q75) (SD) (Q25; Q75) (n) (n) (n) p-value
b
return to oestrus rate (%) 13.52 12a 10.18 9.9a < 0.001 74.8 5.3 19.8
(n = 131) (6.65) (8.8; 18) (4.61) (7; 12) (98) (7) (26) < 0.001
abortion rate (%) 2.31 1.45a 1.42 1a < 0.001 57 21.5 21.5
(n = 93) (2.52) (0.8; 3.0) (1.67) (0.4; 2.1) (53) (20) (20) < 0.001
stillbirth rate (%) 7.79 7.8a 7.95 8.2a > 0.05 40 8.0 52
(n = 50) (3.75) (5.3; 9.8) (3.44) (6.8; 9.9) (20) (4) (26) 0.376
piglets born alive/litter (n) 13.24a 13.2 13.56a 13.5 0.001 25.9 3.7 70.4
(n = 54) (1.12) (12.5; 13.6) (1.17) (12.8; 14.2) (14) (2) (38) 0.001
preweaning mortality (%) 14.34 14.7a 13.59 13.7a 0.023 49.6 16 34.4
(n = 125) (3.5) (12.5; 16) (4.0) (11.6; 16) (62) (20) (43) 0.08
piglets weaned/sow/year (n) 26.06a 26.2 27.39a 27.2 < 0.001 18.1 4.8 77.1
(n = 105) (3.03) (23.8; 28.5) (3.15) (25.5; 29.9) (19) (5) (81) < 0.001
acomparison of the parameters before and after immunisation, t-test or Wilcoxon signed-rank test, respectively
bstagnation was not included in the chi-squared test
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because valid data were not available for each assessed re-
productive parameter from all farms (Table 1).
The farms were categorised according to the return
to oestrus rate before the immunisation. The results
of the subsequent analysis show that a high return to
oestrus rate before vaccination is associated with a
greater decrease in the return to oestrus rate after
vaccination. Between the categories significant devia-
tions (p < 0.001) in the decrease in the return to
oestrus rate were observed (Table 2).
After immunisation the abortion rate decreased sig-
nificantly (p < 0.001) by an average of 1.8% (± 2.24)
in 57% of the farms (Table 1). The number of piglets
born alive increased significantly (p = 0.001) in 70.4%
of the farms (Table 1) by an average of 0.6 (± 0.5)
piglets. Analysis of the preweaning mortality rate re-
sulted in a significant average reduction (p = 0.023) of
2.29% (± 1.9) in 49.6% of the farms (Table 1). In
34.4% of the farms, it increased by an average of 1.7%
(± 1.4) and in 16% of the farms (n = 20/125), it
remained unaltered. Concurrently, an increase of an
average of 1.98 piglets (± 1.82) weaned per sow per
year was observed in 77.1% of the farms. However, in
18.1% of the farms (n = 19/105), the number of
piglets weaned per sow per year decreased by 1.08
piglets.
According to an ANOVA, there was no influence of
the month of vaccination on the reproductive perform-
ance parameters, except for the month of August on the
preweaning mortality (Additional file 1, Table S3).
Linear regression revealed no association between
herd size and reproductive performance parameters
(Additional file 1, Table S4 and Table S5). Addition-
ally, no association between pre-vaccination of farms
against other IAV subtypes and the return to oestrus
rate, the abortion rate, the stillbirth rate, the number
of piglets born alive/litter or the preweaning mortality
rate was observed (Additional file 1, Table S6). How-
ever, the number of piglets weaned/sow/year observed
after the implementation of vaccination against pan-
demic IAV was significantly (p = 0.016) higher in
farms that were already pre-vaccinating against other
influenza subtypes than in farms that were not doing
so (Additional file 1, Table S6).
Discussion
Pandemic influenza can induce respiratory disease, such
as coughing and dyspnea, as well as elevated body
temperature, anorexia and apathy. The results of the
survey concerning the clinical signs of the infection with
pandemic IAV coincide with the observations of numer-
ous experimental studies and case reports [4, 11, 21].
Interestingly, in the present study, reproductive disor-
ders were present in nearly 80% of the assessed farms. A
connection between reduced reproductive performance
and infection with IAV is described in the literature, but
data confirming a causal link is lacking. Furthermore,
the pathogenesis of reproductive disorders subsequent
to infection with IAV is not definitively determined. Al-
terations of the maternal immune system during preg-
nancy can result in an increased likelihood of influenza
virus infection [22]. The few studies examining the effect
of infection with IAV during pregnancy were conducted
mainly with rodent models [22, 23]. Thus, interpretation
of these studies is hampered by histological dissimilar-
ities of the rodent placenta and the of swine placenta
[24]. It is assumed that reproductive disorders due to in-
fluenza virus infections are indirectly caused by systemic
consequences of the infection [25], particularly by fever
and immunological reactions leading to hormonal imbal-
ances [26, 27]. An increase in proinflammatory gene ex-
pression after infection with influenza virus results in
the release of inflammatory cytokines [28, 29]. The
pathological consequence of the infection may be re-
duced progesterone synthesis in the corpus luteum in
pregnant animals [23]. Consequently, a low progester-
one level induces luteolysis and termination of preg-
nancy [30].
The vast majority of the sow herds in the present study
showed reproductive disorders. After confirmation of an
infection with pandemic IAV, the herds were immunised
against the pandemic influenza A (H1N1)pdm09 virus.
Immunisation against IAV can reduce clinical disease,
virus shedding and transmission in infected animals [31,
32]. It was shown previously that by immunisation with
the vaccine used in the current study, the viral lung load,
virus shedding and clinical parameters such as dyspnoea
and elevated body temperature can be reduced in animals
infected with pandemic influenza A (H1N1) virus [33, 34].
Table 2 Categorisation of farms prior to vaccination and respective means of return to oestrus rate after vaccination
category (range of return to oestrus
rate)
n decrease of the return to oestrus rate on n farms
(%)
mean decrease of the return to oestrus rate by X%
(SD)
1 (< 10%) 43 25 (58.1%) 1.56 (1.43)a
2 (≥ 10% - < 20%) 66 52 (78.8%) 4.49 (2.87)b
3 (≥ 20%) 22 21 (95.5%) 10.97 (5.4)c
n = number of farms X = average decrease in the return to oestrus rate in the respective category after immunisation abc groups with different superscripts had
significantly different results(p < 0.05)
Gumbert et al. Porcine Health Management             (2020) 6:4 Page 3 of 9
Reduction in viral lung load and viral shedding after
immunisation correlates with reduced proinflamma-
tory cytokine secretion and therefore with the extent
of the disease [35].
In the current study, the analysis of the performance
parameters revealed significant alterations in the sow
herds for the time period after immunisation compared
to those for the time period before vaccination. The re-
sults for the return to oestrus rate as well as the abortion
rate showed, on average, a significant decline after im-
munisation. Classification of the herds into categories
based on the average return to oestrus rate during the
time period before vaccination revealed significant dif-
ferences between the groups. The percentage of return-
ing sows and the ratio of reduction in the return to
oestrus rate after vaccination differed significantly. The
return to oestrus rate was significantly more reduced
after vaccination in sow herds with a high return to
oestrus rate before vaccination than in sow herds with a
low return to oestrus rate.
It might be hypothesised that the severe clinical out-
come of IAV infection in herds might be caused by an
additive effect of non-infectious factors as well as coin-
fections stimulating the immune system in herds with a
high return to oestrus rate. It has been shown in experi-
mental studies that a significantly stronger inflammatory
response is induced when IAV infection is accompanied
by coinfections [36]. Additionally, it has been proven
that non-infectious factors such as poor hygienic condi-
tions can stimulate the immune system [37, 38]. This
finding could be another explanation of why under ex-
perimental conditions, usually with high hygienic stan-
dards and under the absence of coinfectious agents, the
clinical course of reproductive losses cannot be consist-
ently reproduced [19, 20].
Thus, vaccination in herds with a severe clinical out-
come might lead to a more intense reduction in the re-
turn to oestrus rate than in herds with mild clinical
outcomes. This hypothesis could not be proven by our
observation, as it was beyond the scope of the study to
perform a detailed assessment of internal biosecurity on
the farms or to investigate coinfections other than those
known at the beginning of the study. Nevertheless, the
varying pathogenicity of different influenza virus strains
must also be considered in herds with varying severity in
their clinical course [11].
In contrast to the literature, in which an increased oc-
currence of stillbirths after infection with IAV is de-
scribed in case reports and experimental studies [15, 18,
39, 40], the stillbirth rate was not altered significantly in
the current study. The literature shows that over 70% of
stillborn piglets die during parturition caused by non-
infectious reasons such as asphyxia or dystocia [41], and
only 30% can be attributed to infectious agents. Usually,
there are also only a few litters involved [15, 18]; thus, the
cases where this pathogenesis could have been seen in the
current study are probably overlaid by the usual losses.
Furthermore, as the numbers of farms with an increasing
and decreasing stillbirth rate were not significantly differ-
ent, a tendency for improvement was not seen.
Interestingly, this report is the first study describing a
significant improvement in the parameters number of
piglets born alive per litter, preweaning mortality and
piglets weaned per sow and year after immunisation
against IAV. On average, these reproductive parameters
reached the respective herd-specific benchmark range.
The difference in the number of herds with an increas-
ing or a decreasing preweaning mortality rate tended to
be significant (p = 0.08); for the other parameters, ana-
lyses revealed significant differences.
Overall, there was a significant improvement in the re-
productive parameters. With the exception of three
farms, improvement of at least one reproductive param-
eter was observed after vaccination. However, the alter-
ation of each parameter differed between farms. These
individual levels of influenza affectedness of the single
parameter can be explained by various assumptions.
There may be different IAV infection time points affect-
ing not all sows in all different gestational states, result-
ing in different clinical outcomes apparent in the
reproductive parameters. Perhaps in the three farms
with no improvement in reproductive performance after
vaccination IAV infection either remained subclinical or
manifested in respiratory disease rather than in repro-
ductive disorders. Furthermore, as it is described that
the infection dynamic of IAV can vary from endemic to
short epidemic patterns [42], it could be assumed that
the assessed time periods did not include the time of
clinical disease in the mentioned farms. Additionally, the
presence of stress or other immunosuppressive agents
might have adversely affected the onset of immunity.
After all, vaccine management and handling procedures
were not monitored, so lack of compliance might be a
possible cause as well. The analysis of the effect of pre-
vaccination of some herds against other influenza sub-
types revealed that the number of piglets weaned per
sow and year improved significantly (p = 0.016) more in
herds pre-vaccinating sows than in herds that only vacci-
nated against the pandemic IAV. Repeated vaccination
of pigs with antigens of different IAV strains can induce
slight cross-reactions in neutralisation tests with pan-
demic influenza viruses [43]; however, cross-protective
immunity cannot be achieved [44]. The parameter pig-
lets weaned per sow and year is only indirectly affected
by the vaccine through improved colostrum quality and
quantity transferred from healthier sows and a reduction
in virus shedding in the farrowing unit. Thus, the results
of the current study may indicate improved conditions
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for piglet health in the farrowing unit when sows are
pre-vaccinated against other influenza strains.
Since the current study is a field study, the conditions
of every farm are variable and subject to bias. This con-
dition implies that the included farms varied in health
status, genetic origin of the animals, management and
geographical location. Hence, only the change in param-
eters within each sow herd was analysed so that a major
part of the factors influencing reproductive performance
[45–47] remained unaltered during the observation
period. Furthermore, analyses revealed that there was no
association between herd size and reproductive perform-
ance in the current study.
However, to reduce bias, farms with known coinfec-
tions, change in vaccination scheme or any other factor
that could influence reproduction were excluded from
the study. Except for the start of vaccination against
pandemic influenza A farms were not allowed to imple-
ment any changes in management. Apart from farm-
specific features, a common concern is the variability in
reproduction and infection rate caused by seasonality
[48, 49]. In the current study, infection took place
throughout the year (Additional file 1, Table S2), which
is in accordance with results from current studies [12,
50]. In addition, no seasonal influence on reproductive
parameters was observed. An association between the
month and reproduction was not measurable in the
statistical analysis (Additional file 1, Table S3), with the
exception of the parameter preweaning mortality in the
month of August (p = 0.037). However, because the
model is based on few case numbers, this sole value
should not be overrated.
The study has some potential limitations because po-
tential infectious confounders were not evaluated. To
verify the causality of the present findings experimental
studies need to be conducted under controlled condi-
tions, which was beyond the scope of the current study.
However, given that until now, it was not possible to ex-
perimentally reproduce the pathogenesis of reproductive
disorders due to influenza A virus infection [19, 20], the
present results support the common assumption of an
association. The findings of the current field study are
substantiated through the combination of the large num-
ber of cases and the different assessed parameters pre-
dominantly showing the same results.
Conclusion
The results of the current field study evaluating the re-
productive performance of 137 sow herds provide data
supporting the often described but seldomly scientifically
verified causal link between infections with IAV and re-
duced reproductive performance. An improvement in
reproductive performance by vaccination the against in-
fluenza A (H1N1)pdm09 virus in sow herds infected
with the respective virus could be achieved. The large
number of herds (n = 137) and animals (n = 60,153) in-
cluded show the importance of influenza virus infection
for conventional farms.
Methods
The aim of the present longitudinal field study was to
evaluate reproductive performance parameters after the
implementation of a vaccine against the influenza A
(H1N1)pdm09 virus in sow herds infected with pan-
demic influenza A virus.
The study is based on data from commercial swine
breeding herds in Germany. A total of 315 sow herds in-
fected with pandemic influenza A virus were included.
Infection with the pandemic influenza A virus was
verified by laboratory investigations. In 43 farms of the
finally assessed 137 farms (see below), the infection with
the aforementioned subtype was confirmed by detection
of pandemic IAV-RNA by polymerase chain reaction
(PCR). Due to the short period of virus shedding after
infection [51], farms (94 farms) with the presence of
antibodies against pandemic IAV detected by haem-
agglutination inhibition (HI) were also included in the
study. The HI test was performed to detect antibodies
against the pandemic IAV and the major European sub-
types H1N1, H1N2 and H3N2. In the case of the pres-
ence of antibodies against different subtypes, the
respective farm was only included if the titre against
H1pdmN1 was twofold higher than that against the
other subtypes. However, due to the occurrence of pos-
sible cross-reactivity in the HI test with other influenza
subtypes [52], farms with questionable serologic results
were excluded.
The 315 farms were part of an extended field study that
was conducted to achieve market authorisation for the
vaccine against the pandemic influenza A (H1N1)pdm09
virus (RESPIPORC FLUpanH1N1, IDT Biologika GmbH)
by the European Marketing Agency. The field study was
conducted in accordance with paragraph 11 section 1 of
the German animal health law (formerly paragraph 17 c of
the law on epizootic diseases). For the permission of such
preregistration trials, either the detection of the virus by
PCR or a positive HI test is a mandatory requirement.
In this field trial, primary vaccination was performed
on all farms as a classical mass vaccination of all sows,
consisting of two vaccinations at an interval of 3 weeks.
The time period between the first occurrence of clinical
signs related to influenza infection in the herd and the
diagnosis and administrative approval differed between
herds from 3 to 12 weeks.
The first step of the present study was to collect farm-
specific data as well as information on the clinical presen-
tation of the infection on the 315 farms via a standardised
questionnaire (Additional file 2). Based on the results of
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the questionnaire, data from only 137 farms were statisti-
cally analysed. The reasons for exclusion were factors that
could bias the data, such as restocking of the sow herds,
depopulation and repopulation, lack of vaccine compli-
ance or change in the internal biosecurity as well as exter-
nal biosecurity measures. Additionally, farms with known
coinfections with other pathogens, including influenza
viruses other than the pandemic subtype, were ex-
cluded from the study. However, no further diagnostic
investigations assessing coinfections were performed
during this study.
To evaluate reproductive performance, the production
parameters of the sow herds were recorded for 6 months
before implementation of the vaccine and 6months after
completion of primary vaccination. Because the primary
basic vaccination consists of two vaccinations at an
interval of 3 weeks, this period of 3 weeks was not in-
cluded in the data records. In detail, the return to
oestrus rate, abortion rate, stillbirth rate, piglets born
alive per litter, preweaning mortality rate and number of
piglets weaned per sow per year were assessed based on
routinely recorded production data that were obtained
monthly whenever possible. However, the information
value of the monthly data was limited due to differing
batch farrowing intervals that would distort the monthly
data. Therefore, in the current analyses, the data were
reduced for every farm to two data points summarising
the two time periods (6 months before implementation
of the vaccine and 6months after completion of primary
vaccination) to ensure comparability between farms. The
farms were categorised by means of the return to oestrus
rate before vaccination. The categories were chosen by
the following benchmarks: return to oestrus rate < 10%
(category 1), return to oestrus rate ≥ 10% and < 20% (cat-
egory 2) and return to oestrus rate ≥ 20% (category 3),
based on a literature review and industry reports charac-
terising average German performance data [53–55]. Sub-
sequently, the alteration in the return to oestrus rate
after the implementation of the vaccine was assessed for
the different categories.
The 137 included farms comprised 104 piglet produ-
cing farms, 27 farrow-to-finish herds and 6 multiplier
herds. In total, 111 farms were already vaccinating
against other subtypes of IAV prior to the implementa-
tion of the pandemic IAV vaccine. The herd size ranged
from 38 to 5600 sows, with a mean of 448 sows (Fig. 1).
In total, 60,153 sows were included. The locations of
the included farms reflect the geographical distribution
of the pig population in the German federal states
(Table 3).
Statistical analysis
The collected data from the questionnaires were sum-
marised in a database using Microsoft Excel® 2010 (Fa.
Microsoft, Redmond, USA) and analysed statistically in
IBM SPSS® Statistics Version 23.0 (Fa. IBM Corp.
Armonk, USA). For descriptive statistics, an exploratory
data analysis was carried out. Subsequently, a Wilcoxon
signed-rank test or a paired t-test was performed on the
paired samples, depending on wether the metric vari-
ables were normally distributed. To test whether the
numbers of herds with increasing or decreasing repro-
ductive parameters differed, a one-sample chi-square test
Fig. 1 Herd sizes of the included farms
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was performed. For analysis of variance (ANOVA), R
software version 3.3.12016 (R Core Team, Vienna,
Austria) was used. To test the association between herd
size and reproductive performance or vaccination
against other IAV subtypes and reproductive perform-
ance, a linear regression model was employed. Each farm
was considered a statistical unit. The applied level of sig-
nificance was 5% (p < 0.05).
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